why choose us

First received: October 10, 2022

Clinical Trial: Autologous Hair Follicle Derived Mesenchymal Stem Cell Suspension to Treat AGA

Study Status: Completed

Recruit Status: Completed

Condition: Hair Transplantation

Study Type: Interventional


Official Title: A Randomized-controlled Clinical Trial to Treat Chinese Advanced AGA With Autologous Hair Follicle Derived Mesenchymal Stem Cell Suspension

Brief Summary: Androgenic alopecia (AGA) is characterized by progressive hair follicle miniaturization, and novel treatments are needed to intervene in the miniaturization process. The investigators aimed to evaluate the efficacy, safety, effectiveness, and effective population of autologous hair follicle mesenchymal stem cell therapy for the treatment of advanced AGA in Chinese people.50 participants ranging from 25 to 45 years old, with an average age of 32 ± 1.24 years were included. None of them had ever used minoxidil,…

Read more